herp
simplex
common
infecti
agent
precis
detail
entri
infect
cell
begun
clarifi
four
viral
surfac
glycoprotein
gb
gd
gh
gl
requir
review
summaris
known
structur
function
essenti
viral
envelop
glycoprotein
explor
known
close
cooper
mediat
cellular
membran
fusion
suggest
follow
gd
bind
one
entri
receptor
membran
fusion
mediat
gb
heterodim
ghgl
significantli
four
entri
glycoprotein
also
play
key
role
interact
hsv
host
immun
system
glycoprotein
serv
import
role
target
adapt
immun
howev
recent
studi
demonstr
protein
also
play
key
role
initi
earli
innat
immun
respons
hsv
understand
complex
function
hsv
protein
may
essenti
success
develop
vaccin
hsv
herp
simplex
one
common
pathogen
agent
capabl
infect
human
age
viru
occur
worldwid
infect
result
wide
varieti
clinic
manifest
rang
asymptomat
infect
rel
minor
nonetheless
signific
common
morbid
seen
ulcer
vesicular
lesion
skin
mucosa
sporad
enceph
seriou
long
term
sequela
mortal
herp
simplex
viru
hsv
virion
consist
electron
dens
core
contain
doubl
strand
linear
dna
enclos
icosahedr
capsid
capsid
surround
proteinac
layerth
tegumentand
lipid
bilay
envelop
surfac
viral
envelop
protein
infect
cell
cultur
requir
coordin
action
least
four
glycoprotein
gd
b
gb
heterodim
h
gh
l
gl
gener
believ
hsv
entri
cell
occur
direct
fusion
virion
envelop
outer
plasma
membran
recent
report
suggest
howev
least
three
divers
pathway
implic
entri
differ
cell
type
suscept
infect
via
direct
fusion
plasma
membran
via
fusion
within
acid
endosom
via
fusion
within
neutral
endosom
fusion
plasma
membran
known
occur
vero
cell
phindepend
fashion
cell
type
virion
entri
endocytosi
also
variabl
exampl
hela
cell
primari
human
keratinocyt
cell
transfect
gdreceptor
fusion
endosom
membran
requir
low
ph
environ
contrast
viru
entri
mous
melanoma
cell
express
human
gd
receptor
also
involv
virion
endocytosi
fusion
requir
low
ph
furthermor
viru
internalis
melanoma
cell
complet
depend
upon
express
gd
receptor
pathway
fusion
requir
gd
gb
ghgl
gd
receptor
still
unclear
howev
whether
glycoprotein
act
way
form
similar
fusion
complex
whether
cellular
compon
involv
differ
entri
pathway
review
concentr
viral
entri
glycoprotein
role
fusion
cellular
membran
influenc
host
immun
respons
hsv
entri
occur
extracellular
virion
attach
cell
surfac
via
gc
gb
bind
gd
receptor
activ
membran
fusion
machineri
compris
gb
heterodim
ghgl
figur
cell
viru
endocytosi
occur
attach
step
membran
fusion
concomit
viru
bind
cell
surfac
membran
fusion
mediat
gd
gb
ghgl
activ
intracellular
immunosignal
process
initi
step
entri
mammalian
cell
attach
viru
cell
surfac
gc
gb
interact
independ
heparan
sulfat
hs
proteoglycan
promot
initi
attach
yet
glycoproteinh
interact
although
import
absolut
essenti
viral
entri
least
infect
cultur
cell
viru
mutant
gb
polylysin
sequenc
respons
gbh
interact
still
infecti
although
viru
bind
reduc
viru
lack
gc
glycoprotein
also
still
infecti
gb
gc
absent
viru
bind
cell
surfac
figur
model
direct
entri
fusion
cellular
membran
initi
although
mandatori
gb
togeth
gc
bind
heparan
sulfat
proteoglycan
hspg
b
unknown
gb
receptor
independ
hs
c
allow
viruscel
attach
follow
gd
bind
cell
surfac
receptor
hvem
heparan
sulfat
gd
undergo
conform
chang
transmit
signal
gb
andor
ghgl
gb
possibl
interact
unknown
cell
surfac
compon
gb
ghgl
form
fusion
machineri
interact
cellular
membran
e
gb
ghgl
mediat
cell
fusion
entri
viral
capsid
f
gb
gh
gl
work
togeth
achiev
fusion
unclear
step
drawn
hypothet
sever
reduc
infect
complet
abolish
virion
could
due
gb
critic
role
membran
fusion
rather
virion
attach
cell
surfac
recent
data
suggest
howev
anoth
receptor
independ
hs
may
mediat
interact
gb
cell
surfac
sinc
solubl
form
gb
shown
interact
surfac
differ
cell
type
independ
hs
exact
natur
nonh
gb
receptor
still
unknown
role
attach
andor
fusion
remain
determin
entri
receptor
interactionglycoprotein
follow
gc
andor
gb
interact
cell
surfac
next
stage
viral
entri
requir
interact
gd
one
sever
potenti
entri
receptor
herpesviru
entri
mediat
hvem
member
tnf
receptor
famili
b
member
immunoglobulin
superfamili
c
heparan
sulphat
differenti
use
receptor
import
may
help
account
entri
hsv
wide
rang
differ
cell
type
glycoprotein
type
membran
glycoprotein
consist
amino
acid
ntermin
ectodomain
amino
acid
three
nlink
oligosaccharid
attach
site
protein
ectodomain
core
vlike
domain
immunoglobulin
fold
residu
within
ntermin
extens
core
residu
hairpin
structur
bend
residu
form
entir
site
contact
receptorhvem
absenc
hvem
nterminu
adopt
extend
flexibl
conform
sinc
receptor
bind
differ
area
requir
ntermin
hairpin
gd
suggest
interact
gd
nterminu
extend
unbent
conform
ctermin
extens
residu
also
play
vital
role
viral
entri
stage
similar
ntermin
extens
ctermin
flexibl
flexibl
necessari
correct
gd
function
cterminu
gd
ectodomain
past
residu
particip
direct
interact
either
receptor
rather
wrap
around
gd
core
block
format
hvem
bind
hairpin
time
conceal
residu
involv
bind
mutagenesi
gd
cterminu
shown
residu
necessari
anchor
bring
cterminu
close
proxim
nterminu
henc
interf
receptor
bind
structur
gd
prereceptor
bind
form
suggest
order
receptor
bind
cterminu
must
move
furthermor
movement
cterminu
upon
bind
receptor
import
function
gd
activ
mechan
lead
membran
fusion
mutat
gd
insertionsdelet
cterminu
residu
found
impair
cell
entri
furthermor
solubl
form
gd
residu
shorter
form
found
suffici
rescu
infect
noninfecti
gdnull
hsv
mutant
suggest
follow
gd
bind
one
cellular
entri
receptor
gd
may
transmit
signal
gb
andor
ghgl
interact
cellular
membran
mediat
cell
fusion
signal
found
trigger
prolin
rich
region
cterminu
gd
residu
locat
proxim
viral
membran
name
profus
domain
pfd
figur
sever
studi
also
shown
role
gd
inhibit
cell
apoptosi
ref
complex
least
understood
stage
entri
mammalian
cell
fusion
virion
envelop
cellular
membran
absenc
gb
gh
gl
hsv
enter
target
cell
sinc
gd
characterist
fusion
protein
assum
central
fusion
machineri
involv
gb
heterodim
ghgl
mani
virus
fusion
process
preform
specif
protein
viral
membran
date
two
complet
unrel
structur
class
identifi
design
type
type
ii
fusion
protein
type
model
identifi
orthomyxovirus
paramyxovirus
retrovirus
filovirus
coronavirus
fusion
protein
form
homotrim
cleav
proteolyt
surfac
su
subunit
transmembran
tm
subunit
anchor
viral
membran
fusion
protein
extend
rodlik
structur
respons
activ
trigger
hydrophob
helix
fusion
peptid
nterminu
tm
subunit
expos
abl
penetr
target
cell
membran
conform
chang
tm
subunit
bring
togeth
two
heptad
repeat
locat
downstream
fusion
peptid
form
coil
coil
structur
result
stabl
hairpin
shape
conform
fold
back
fusion
protein
upon
bring
viral
cellular
membran
close
contact
allow
lipid
outer
membran
mix
type
ii
model
applic
flavivirus
alphavirus
fusion
protein
bear
intern
fusion
peptid
fold
flat
viral
surfac
tight
associ
second
protein
heterodim
activ
cleavag
occur
second
protein
receptor
bind
lead
irrevers
rearrang
fusion
protein
trimer
protrud
viral
envelop
allow
penetr
expos
hydrophob
hairpin
loop
target
cell
membran
foldback
movement
fusion
protein
bring
viral
cellular
membran
togeth
contrast
hsv
member
herpesvirus
peculiar
reli
three
distinct
glycoprotein
gb
gh
gl
addit
receptor
bind
gd
fusion
key
role
fusion
thought
play
glycoprotein
b
h
conserv
glycoprotein
herpesvirida
famili
one
actual
perform
membran
fusion
still
debat
howev
recent
advanc
structur
hsv
fusion
glycoprotein
indic
herpesvirus
may
use
kind
intermedi
mechan
compon
similar
type
type
ii
organis
gh
resembl
viral
fusion
glycoproteinsa
possibl
helix
contain
within
ectodomain
gh
residu
characterist
intern
fusion
peptid
carboxytermin
hydrophob
region
propos
three
segment
contain
amino
acid
correspond
residu
segment
segment
segment
travers
membran
three
time
studi
use
mutant
delet
predict
membraneanchor
sequenc
suggest
segment
membraneanchor
domain
segment
may
peripher
associ
membran
recent
solv
crystal
structur
gb
reveal
trimer
ectodomain
made
five
distinct
domain
protom
identifi
iv
rodshap
trimer
organis
around
central
helic
core
reminisc
type
fusion
protein
hand
hsv
gb
proteolyt
cleav
might
contain
intern
fusion
peptid
similar
type
ii
fusion
protein
studi
involv
virusneutralis
monoclon
antibodi
direct
toward
specif
site
gb
ectodomain
found
antibodi
affect
fusion
react
residu
midregion
ectodomain
suggest
domain
iv
gb
ectodomain
expos
surfac
virion
may
requir
viral
penetr
cell
fusion
interestingli
hsv
gb
ectodomain
structur
homolog
fusion
protein
g
vesicular
stomat
viru
vsv
rhabdoviru
singlestrand
rna
genom
protein
g
vsv
known
viral
fusion
protein
structur
similar
strongli
suggest
gb
might
effector
membran
fusion
hsv
entri
regardless
gb
gh
central
fusion
effector
glycoprotein
must
act
concert
promot
viru
entri
activ
gd
bind
cell
receptor
machineri
function
remain
elucid
detail
studi
glycoprotein
highlight
sever
import
aspect
infect
particular
envelop
virus
reli
one
two
glycoprotein
fusion
viru
common
member
alphaherpesviru
subfamili
requir
complex
interact
four
glycoproteinsgb
gd
gh
gl
appear
four
surfac
glycoprotein
well
act
viral
entri
cell
also
play
key
role
immun
respons
wellestablish
target
effector
tand
bcell
also
document
recent
studi
laboratori
initi
induct
innat
immun
modul
dendrit
cell
dc
function
sever
studi
show
surfac
glycoprotein
target
adapt
respons
anim
experi
suggest
viral
glycoprotein
gd
induc
neutralis
antibodi
furthermor
mice
immunis
passiv
monoclon
antibodi
gb
gc
gd
immunis
activ
either
recombin
synthet
viral
glycoprotein
protect
lethal
viru
challeng
specif
neutralis
antibodi
also
obtain
respons
ghgl
heterodim
although
protect
effici
viral
challeng
vari
consider
publish
studi
like
antigen
specif
antibodi
probabl
import
compon
adapt
host
immun
respons
due
cytotox
tcell
ctl
respond
specif
viral
antigen
variou
report
show
gd
gb
lesser
extent
gh
serv
target
antigen
ctl
primari
infect
also
hladr
tcell
lesion
cytotox
activ
tcell
shown
recognis
gb
gh
gd
glycoprotein
presum
peptid
deriv
glycoprotein
initi
present
mhc
class
andor
class
ii
apc
henc
pathway
also
implic
dc
noteworthi
howev
hsv
evolv
sever
method
evad
ctl
facilit
persist
host
relev
present
review
gd
bind
hvem
implic
interf
nuclear
factorb
nfb
signal
pathway
henc
tcell
activ
form
evas
describ
discuss
detail
sinc
directli
involv
surfac
glycoprotein
past
effort
develop
hsv
vaccin
human
use
rang
construct
live
attenu
viru
use
recombin
viral
subunit
howev
date
fail
reach
endpoint
protect
infect
clinic
trial
although
success
protect
wildtyp
challeng
anim
model
live
modifi
construct
poor
immunogen
phase
clinic
trial
recombin
glycoprotein
vaccin
given
promis
result
anim
model
recombin
gd
induc
antibodi
respons
japanes
macaqu
could
increas
follow
intracutan
boost
variabl
tcell
respons
also
detect
suggest
vaccin
might
valuabl
infect
also
herp
b
viru
infect
express
homolog
gd
protein
caus
lethal
encephalomyel
transmit
human
interest
novel
approach
thu
far
also
report
mice
develop
synthet
lipopeptid
lipid
moieti
act
adjuv
via
dc
gd
peptid
specif
antigen
tcell
respons
induc
may
well
act
via
pathway
sinc
express
viru
also
induc
degre
viral
clearanc
ocular
herp
model
recombin
gb
gd
protein
also
use
candid
subunit
vaccin
human
subject
thu
far
combin
recombin
gdgb
subunit
vaccin
adjuv
despit
induc
high
titr
specif
antibodi
provid
transient
protect
infect
anoth
recombin
gd
vaccin
given
effect
adjuv
also
fail
produc
full
protect
infect
although
resist
demonstr
women
seroneg
hsv
time
vaccin
readili
infect
macrophag
dc
lead
seri
function
chang
antigen
present
capabl
impair
despit
outlin
host
usual
abl
overcom
acut
phase
infect
mount
strong
immun
respons
link
product
rang
immedi
cytokin
preced
control
evolut
antibodi
cytotox
tcell
respons
interestingli
least
one
phase
earli
respons
cytokin
product
depend
viral
glycoprotein
interact
cell
surfac
initi
molecular
interact
requir
viral
entri
appear
also
activ
cellular
signal
pathway
respons
earli
burst
type
interferon
ifn
secret
may
key
capac
host
overcom
infect
infect
immatur
dc
lead
seri
morpholog
function
chang
partial
dc
matur
judg
surfac
phenotyp
time
concomit
impair
antigen
present
function
eventu
apoptosi
exact
pathway
enter
dc
characteris
although
like
occur
similar
fashion
cell
type
via
bind
gd
one
two
entri
receptor
hvem
follow
gb
andor
ghgl
mediat
membran
fusion
interest
gd
bind
hvem
trigger
direct
signal
respons
lead
nfb
activ
similar
way
light
known
member
tumour
necrosi
monoblastlik
cell
line
link
apoptot
pathway
inhibit
apoptosi
primari
cell
process
thought
lead
secret
type
ifn
respons
first
wave
viral
control
studi
shown
type
ifn
releas
hsv
infect
dc
addit
antivir
activ
also
act
danger
signal
bystand
uninfect
dc
induc
matur
releas
migrat
dc
crosspres
antigen
would
promot
effect
immun
respons
provid
link
immedi
adapt
phase
figur
thu
interact
viral
glycoprotein
dc
surfac
may
critic
process
occur
essenti
part
earli
step
viru
infect
entri
glycoprotein
hsv
target
antivir
drug
develop
also
candid
vaccin
compon
recent
advanc
understand
structur
function
increas
knowledg
earli
interact
viru
target
cell
includ
cell
immun
system
role
glycoprotein
play
earli
immun
respons
bind
apc
becom
appar
howev
addit
knowledg
hsv
glycoprotein
structur
function
cellular
entri
specif
role
initi
immun
respons
contribut
ration
design
effici
vaccin
hsv
